Circulating hematopoietic progenitor cells are decreased in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 3, 2014, Pages 277-289

  Janssen, William J ^a,b   Yunt, Zulma X ^a,b   Muldrow, Alaina ^a   Kearns, Mark T ^b   Kloepfer, Angela ^b   Barthel, Lea ^b   Bratton, Donna L ^a   Bowler, Russell P ^a,b   Henson, Peter M ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Angiogenesis; Emphysema; Endothelial progenitor cell

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONY FORMING UNIT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EMPHYSEMA; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SMOKING; SPIROMETRY; BLOOD; CELL COUNT; CFU COUNTING; CHEMISTRY; COMPLICATION; FORCED EXPIRATORY VOLUME; LUNG EMPHYSEMA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD45; CELL COUNT; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FORCED EXPIRATORY VOLUME; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VITAL CAPACITY;

EID: 84900801509     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.841668     Document Type: Article

References (77)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Measuring the global burden of disease and risk factors. Lancet 2006; 367:1747-1757.
2. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125:626-632. (Pubitemid 38223645)
3. Liebow AA. Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis 1959; 80:67-93.
4. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163:737-744. (Pubitemid 32230838)
5. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 2005; 25:250-258. (Pubitemid 40246524)
6. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases a and b, collagenases 1 and 2, and increased parenchymal cell death in copd. Chest 2000; 117:684-694. (Pubitemid 30152206)
7. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, Fontenot AP, Tuder RM, Voelkel NF. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005; 171:734-742. (Pubitemid 40471144)
8. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of vegf receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106:1311-1319.
9. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29:88-97. (Pubitemid 36783320)
10. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. Vegf is required for growth and survival in neonatal mice. Development 1999; 126:1149-1159. (Pubitemid 29182112)
11. Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, Langley RR, Fidler IJ, Pasqualini R, Tuder RM, Arap W. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem 2008; 283:29447-29460.
12. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing defi nitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531. (Pubitemid 41208561)
13. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identifi cation of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104:2752-2760. (Pubitemid 39434958)
14. Caramori G, Rigolin GM, Mazzoni F, Leprotti S, Campioni P, Papi A. Circulating endothelial stem cells are not decreased in pulmonary emphysema or copd. Thorax 2010; 65:554-555.
15. Fadini GP, Schiavon M, Cantini M, Baesso I, Facco M, Miorin M, Tassinato M, de Kreutzenberg SV, Avogaro A, Agostini C. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006;24:1806-1813. (Pubitemid 44474194)
16. Huertas A, Testa U, Riccioni R, Petrucci E, Riti V, Savi D, Serra P, Bonsignore MR, Palange P. Bone marrow-derived progenitors are greatly reduced in patients with severe copd and low-bmi. Respir Physiol Neurobiol 2010; 170:23-31.
17. Palange P, Testa U, Huertas A, Calabro L, Antonucci R, Petrucci E, Pelosi E, Pasquini L, Satta A, Morici G, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in copd. Eur Respir J 2006; 27:529-541. (Pubitemid 43372527)
18. Bastarrika G, Wisnivesky JP, Pueyo JC, Diaz L, Arraiza M, Villanueva A, Alcaide AB, Campo A, Seijo L, de Torres JP, et al. Low-dose volumetric computed tomography for quantifi cation of emphysema in asymptomatic smokers participating in an early lung cancer detection trial. J Th or Imag 2009; 24:206-211.
19. Spaggiari E, Zompatori M, Verduri A, Chetta A, Bna C, Ormitti F, Sverzellati N, Rabaiotti E. Early smoking-induced lung lesions in asymptomatic subjects. Correlations between high resolution dynamic ct and pulmonary function testing. La Radiol Med 2005; 109:27-39. (Pubitemid 43942448)
20. Tylen U, Boijsen M, Ekberg-Jansson A, Bake B, Lofdahl CG. Emphysematous lesions and lung function in healthy smokers 60 years of age. Respir Med 2000; 94:38-43. (Pubitemid 30113848)
21. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, et al. Association of radiographic emphysema and air flow obstruction with lung cancer. Amer J Respir Crit Care Med 2008; 178:738-744.
22. Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschope C, Schultheiss HP, Zeiher AM, Dimmeler S. Quantifi cation of circulating endothelial progenitor cells using the modifi ed ishage protocol. PLoS One 2010; 5:e13790.
23. Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefi ne endothelial progenitor cells. Leukemia 2007; 21:1141-1149. (Pubitemid 46831802)
24. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: Identity defi ned? J Cell Mol Med 2009; 13:87-102.
25. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, henotype, and fate of endothelial progenitor cells. Arterioscler Th romb Vasc Biol 2008; 28:1584-1595.
26. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, Ferrara N. Vegf regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002; 417:954-958. (Pubitemid 34716872)
27. Larrivee B, Lane DR, Pollet I, Olive PL, Humphries RK, Karsan A. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J Biol Chem 2003; 278:22006-22013. (Pubitemid 36792609)
28. Ziegler BL, Valtieri M, Porada GA, De Maria R, Muller R, Masella B, Gabbianelli M, Casella I, Pelosi E, Bock T, et al. Kdr receptor: A key marker defining hematopoietic stem cells. Science 1999; 285:1553-1558. (Pubitemid 29420577)
29. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, et al. Expression of vegfr-2 and ac133 by circulating human cd34(+) cells identifi es a population of functional endothelial precursors. Blood 2000; 95:952-958. (Pubitemid 30062717)
30. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. Ac133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90:5002-5012. (Pubitemid 28007217)
31. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of copd (copdgene) study design. COPD 2010; 7:32-43.
32. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Amer J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
33. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, et al. Chronic obstructive pulmonary disease exacerbations in the copdgene study: Associated radiologic phenotypes. Radiology 2011; 261:274-282.
34. Kim YI, Schroeder J, Lynch D, Newell J, Make B, Friedlander A, Estepar RS, Hanania NA, Washko G, Murphy JR, et al. Gender differences of airway dimensions in anatomically matched sites on ct in smokers. COPD 2010;8:285-292.
35. Budoff MJ, Nasir K, Kinney GL, Hokanson JE, Barr RG, Steiner R, Nath H, Lopez-Garcia C, Black-Shinn J, Casaburi R. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: Comparison of ungated and gated examinations in patients from the copd gene cohort. J Cardiovasc Comp Tomogr 2011; 5:113-118.
36. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 2006; 69:1037-1042. (Pubitemid 44521985)
37. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003; 348:593-600. (Pubitemid 36204953)
38. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111:2981-2987. (Pubitemid 40814192)
39. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM. Hmg-coa reductase inhibitors (statins) increase endothelial progenitor cells via the pi 3-kinase/akt pathway. J Clin Invest 2001; 108:391-397. (Pubitemid 32730785)
40. Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G, Guelly C, Strunk D. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006; 24:357-367. (Pubitemid 44464805)
41. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, Cosmi L, Maggi L, Lasagni L, Scheffold A, et al. Cd14+cd34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005; 97:314-322. (Pubitemid 41216135)
42. Zhang SJ, Zhang H, Wei YJ, Su WJ, Liao ZK, Hou M, Zhou JY, Hu SS. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 2006; 16:577-584.
43. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-1809. (Pubitemid 46348173)
44. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112:1618-1627. (Pubitemid 41324524)
45. Gelb AF, Schein M, Kuei J, Tashkin DP, Muller NL, Hogg JC, Epstein JD, Zamel N. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 147:1157-1161. (Pubitemid 23149872)
46. Thurlbeck WM. The pathology of small airways in chronic air flow limitation. Eur J Respir Dis Suppl 1982; 121:9-18. (Pubitemid 12015713)
47. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-1360.
48. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of copd and pulmonary emphysema. Respir Res 2006; 7:53.
49. Voelkel NF, Cool C, Taraceviene-Stewart L, Geraci MW, Yeager M, Bull T, Kasper M, Tuder RM. Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit Care Med 2002; 30:S251-256. (Pubitemid 34507999)
50. Csaky KG, Baffi JZ, Byrnes GA, Wolfe JD, Hilmer SC, Flippin J, Cousins SW. Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor. Exper Eye Res 2004; 78:1107-1116. (Pubitemid 38510348)
51. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, Giacca M. Bone marrow mononuclear cells are recruited to the sites of vegf-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006; 107:3546-3554.
52. Steen R, Egeland T. Cd34 molecule epitope distribution on cells of haematopoietic origin. Leukemia Lymphoma 1998; 30:23-30. (Pubitemid 28327252)
53. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF. Expression of the cd34 gene in vascular endothelial cells. Blood 1990; 75:2417-2426. (Pubitemid 20202322)
54. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human cd34+ac133+vegfr-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35:1109-1118. (Pubitemid 46921310)
55. Ferrara N, Gerber HP, LeCouter J. The biology of vegf and its receptors. Nat Med 2003; 9:669-676. (Pubitemid 36749215)
56. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39:469-478. (Pubitemid 44714526)
57. Puls M, Schroeter MR, Steier J, Stijohann L, Hasenfuss G, Konstantinides S, Schafer K. Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells. Int J Cardiol 2011; 152:61-69.
58. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, Inden Y, Murohara T. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Th romb Vasc Biol 2004; 24:1442-1447. (Pubitemid 39050438)
59. Paschalaki KE, Starke RD, Hu Y, Mercado N, Margariti A, Gorgoulis VG, Randi AM, Barnes PJ. Dysfunction of endothelial progenitor cells from smokers and copd patients due to increased DNA damage and senescence. Stem Cells 2013, in press.
60. Dimmeler S. Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Th romb Vasc Biol 2010; 30:1088-1093.
61. Walenta KL, Bettink S, Bohm M, Friedrich EB. Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res Cardiol 2011; 106:299-305.
62. Liu X, Xie C. Human endothelial progenitor cells isolated from copd patients are dysfunctional. Mol Cell Biochem 2011; 363:53-63.
63. Takahashi T, Suzuki S, Kubo H, Yamaya M, Kurosawa S, Kato M. Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease. Respirology 2011; 16:680-687.
64. Henrich D, Seebach C, Wilhelm K, Marzi I. High dosage of simvastatin reduces tnf-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by il-1beta in vitro. J Surg Res 2007; 142:13-19. (Pubitemid 47267991)
65. Xu S, Zhao Y, Yu L, Shen X, Ding F, Fu G. Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by tnf-alpha via erk/mapk and nf-kappab signal pathways. J Pharmacol Sci 2011; 117:265-274.
66. Zhang Y, Herbert BS, Rajashekhar G, Ingram DA, Yoder MC, Clauss M, Rehman J. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. FASEB J 2009; 23:1358-1365.
67. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 1994; 150:1453-1455. (Pubitemid 24356667)
68. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 2004; 59:574-580. (Pubitemid 38901515)
69. Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in copd patients. J Infl amm 2010; 7:29.
70. Liu SF, Chin CH, Wang CC, Lin MC. Correlation between serum biomarkers and bode index in patients with stable COPD. Respirology 2009; 14:999-1004.
71. Peinado VI, Ramirez J, Roca J, Rodriguez-Roisin R, Barbera JA. Identifi cation of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2006; 34:257-263. (Pubitemid 43320706)
72. Chute JP. Stem cell homing. Current opinion in hematology 2006;13:399-406. (Pubitemid 44607440)
73. Faber A, Roderburg C, Wein F, Saffrich R, Seckinger A, Horsch K, Diehlmann A, Wong D, Bridger G, Eckstein V, et al. The many facets of sdf-1alpha, cxcr4 agonists and antagonists on hematopoietic progenitor cells. J Biomed Biotechnol 2007; 260:65-75.
74. Todorova D, Sabatier F, Doria E, Lyonnet L, Vacher Coponat H, Robert S, Despoix N, Legris T, Moal V, Loundou A, et al. Fractalkine expression induces endothelial progenitor cell lysis by natural killer cells. PloS one 2011;6:e26663.
75. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 2010; 209:10-17.
76. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and metaanalysis of controlled clinical trials. J Am Coll Cardiol 2007; 50:1761-1767. (Pubitemid 47600592)
77. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012; 110:624-637.